Medpace Holdings, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
218.33
|
|
Average Rating
|
3.40
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
1.47
|
2.05
|
0.58
|
39.46%
|
|
2022-06-30
|
1.31
|
1.46
|
0.15
|
11.45%
|
|
2022-03-31
|
1.26
|
1.69
|
0.43
|
34.13%
|
|
2021-12-31
|
1.25
|
1.32
|
0.07
|
5.60%
|
|
2021-09-30
|
1.07
|
1.29
|
0.22
|
20.56%
|
|
2021-06-30
|
0.99
|
1.06
|
0.07
|
7.07%
|
|
2021-03-31
|
1.00
|
1.14
|
0.14
|
14.00%
|
|
2020-12-31
|
1.24
|
1.35
|
0.11
|
8.87%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
5.20
|
|
2021-12-31
|
4.81
|
|
2020-12-31
|
3.84
|
|
2019-12-31
|
3.01
|
|
2018-12-31
|
2.59
|
|
2017-12-31
|
1.51
|
|
2016-12-31
|
1.20
|